(Shinjuku-ku, Tokyo; Kazuhiro Hasegawa, President; hereinafter \"Glocalink\") has invested in Neurospace Corporation (Chiyoda-ku, Tokyo; Takanori Kobayashi, President; hereinafter \"Neurospace\"), which promotes corporate health management and productivity improvement through \"sleep technology.<\/p>\n
NeuroSpace has been improving the sleep of many employees by focusing on sleep as a key component of corporate health management. At the same time, we have developed EEG sensing technology and biometric signal processing technology for simple measurement and visualization of sleep conditions through an industry-academia collaboration with the University of Tsukuba.<\/p>\n
(Shinjuku-ku, Tokyo; President: Yukihiro Maru), and is also sponsored by Liverness Inc. The 3rd Tech Plan Grand Prix<\/a>(now Deep Tech Grand Prix), the Rohto Award from Rohto Pharmaceutical Co.<\/p>\n With this funding, Neurospace will continue to cultivate its sleep solution know-how by collaborating with more business companies, university research institutions, and medical institutions, and will build a standard model for solutions to improve people's sleep. At the same time, we will focus on the development of new science and technology to realize comfortable sleep for people.<\/p>\n <\/p>\n \u25a0Past Results<\/p>\n Sommnie, a sleep improvement program for corporate health management, has been introduced at many companies including Yoshinoya Holdings, a major restaurant chain, DeNA, SBS Holdings, Panasonic Solution Technology, and others, and has improved employee sleep.<\/p>\n <\/p>\n \u25a0Related Articles<\/p>\n DeNA-style health management improves sleep for 66% of subjects NeuroSpace's corporate sleep improvement program Sommnie<\/a><\/p>\n